The largest database of trusted experimental protocols

Plentilox3.7 ef1α mcherry vector

Manufactured by Addgene

The PLentiLox3.7-EF1α-mCherry vector is a lentiviral expression vector that drives the expression of the mCherry fluorescent protein under the control of the EF1α promoter. The vector is designed for lentiviral-mediated gene delivery and expression.

Automatically generated - may contain errors

2 protocols using plentilox3.7 ef1α mcherry vector

1

Lentiviral Constructs for miR-221 and QKI-5

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full-length sequence of miR-221 and the full-length coding region of the QKI-5 mRNA (NM_001301085) were amplified by PCR (Table S1) and cloned into the pEIZ-HIV-ZsGreen lentivirus vector and the pLentiLox3.7-EF1α-mCherry vector, a derivative of pLentiLox3.7 (Addgene: #11795), respectively (5 (link)). The lentivirus vectors encoding for the anti-miR-221 construct (miRZip-221) and a non-targeting pre-miRNA (negative control) were purchased from System Biosciences (USA).
+ Open protocol
+ Expand
2

Lentiviral Overexpression of Anti-miR-93 in Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sequence of precursor miR‐93 (mature miR‐93 and its 5′‐ and 3′‐ flanking regions) and the full‐length coding region of the WASF3 mRNA (NM_006646.6 [GenBank]) were amplified by PCR and cloned into the pEIZ‐HIV‐ZsGreen or mCherry lentivirus vector (Addgene: #18121) or the pLentiLox3.7‐EF1α‐mCherry vector, a derivative of pLentiLox3.7 (Addgene: #11795), respectively.18 The lentivirus vectors encoding for the anti‐miR‐93 construct (miRZip‐93) and a nontargeting control (negative control) were purchased from System Biosciences. Lentiviruses were produced as previously described.24 Breast cancer cells were infected with lentivirus constructs at a MOI of 5.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!